|
Volumn 36, Issue 6, 1999, Pages 549-558
|
Adjuvant and neoadjuvant hormonal therapy for prostate cancer
|
Author keywords
Adjuvant therapy; Antiandrogens; Combined androgen blockade; LH RH agonist; Neoadjuvant therapy; Prostate cancer; Radical prostatectomy; Radiotherapy
|
Indexed keywords
ANTIANDROGEN;
CYPROTERONE ACETATE;
FLUTAMIDE;
GONADORELIN ANTAGONIST;
GOSERELIN;
TRIPTORELIN;
CANCER ADJUVANT THERAPY;
CANCER CONTROL;
CANCER STAGING;
CANCER SURVIVAL;
DRUG EFFICACY;
FATIGUE;
GASTROINTESTINAL SYMPTOM;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
IMPOTENCE;
MALE;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
QUALITY OF LIFE;
REVIEW;
SIDE EFFECT;
TREATMENT OUTCOME;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
HUMANS;
MALE;
PATIENT CARE PLANNING;
PATIENT SELECTION;
PROGNOSIS;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
|
EID: 0032743379
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000020047 Document Type: Review |
Times cited : (23)
|
References (76)
|